Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Fuchs Petrolub SE VZO

Start price
Target price
Perf. (%)
€27.44
30.08.22
€35.00
30.08.23
-2.33%
01.09.22

Good culture
Medium risks for its business
Sustainability is important
buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€3.46
30.08.22
-
30.08.23
-9.83%
04.09.22

Could be very worthwhile Investment >20% year
Farfetch Ltd

Start price
Target price
Perf. (%)
€11.99
27.08.22
€7.00
27.08.23
-20.62%
04.09.22

Revenue decline/stagnation expected
Very low/no dividend yield expected
very negative Cash Flow expected
High risks in the balance sheet
buy
Invitae Corp

Start price
Target price
Perf. (%)
€3.32
26.08.22
-
26.08.23
-17.03%
03.09.22

Could be very worthwhile Investment >20% year
buy
Evonik Industries AG

Start price
Target price
Perf. (%)
€19.19
26.08.22
€31.00
26.08.23
0.70%
09.05.23

Could be worthwhile Investment >10% per year
High dividend yield expected
Fair valuation
Medium risks for its business
buy
CTS Eventim AG & Co. KGaA

Start price
Target price
Perf. (%)
€56.80
25.08.22
€65.00
25.08.23
16.20%
29.01.23

Deutsche Lufthansa AG

Start price
Target price
Perf. (%)
€6.07
25.08.22
€5.00
25.08.23
34.60%
26.08.23

Probably not worthwhile Investment
Increased challenges to pay loans and raise capital
Higher risks for its business
Little innovation
buy
TAG Immobilien AG

Start price
Target price
Perf. (%)
€9.25
24.08.22
€12.00
24.08.23
-20.15%
30.05.23

buy
Prosus N.V.

Start price
Target price
Perf. (%)
€62.51
24.08.22
€80.00
24.08.23
1.58%
30.05.23

buy
Valeo S.A.

Start price
Target price
Perf. (%)
€19.07
24.08.22
€24.00
24.08.23
-7.89%
25.08.23

buy
Stabilus SE

Start price
Target price
Perf. (%)
€51.30
24.08.22
€65.00
24.08.23
-4.83%
25.08.23

buy
Schaeffler AG

Start price
Target price
Perf. (%)
€5.34
24.08.22
€7.00
24.08.23
0.28%
25.08.23

buy
Fuchs Petrolub SE VZO

Start price
Target price
Perf. (%)
€27.56
24.08.22
€40.00
24.08.23
-0.44%
30.08.22

Good culture
Medium risks for its business
Sustainability is important
buy
Tui AG

Start price
Target price
Perf. (%)
€15.45
24.08.22
€20.00
24.08.23
-0.94%
30.08.22

Well known brand
Below average Management
Bad culture
buy
Civitas Resources Inc.

Start price
Target price
Perf. (%)
€69.00
23.08.22
€72.00
23.08.23
5.07%
24.08.23

Could be worthwhile Investment >10% per year
BioNTech SE ADR

Start price
Target price
Perf. (%)
€149.00
23.08.22
-
23.08.26
-44.32%
11.03.24

Probably not worthwhile Investment
Ceconomy AG ST

Start price
Target price
Perf. (%)
€1.53
23.08.22
-
23.08.27
28.00%
11.03.24

Probably not worthwhile Investment
buy
TAG Immobilien AG

Start price
Target price
Perf. (%)
€9.43
23.08.22
€13.00
23.08.23
-4.14%
03.09.22

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€5.40
23.08.22
-
23.08.23
29.96%
09.09.22

Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
buy
Albemarle Corp

Start price
Target price
Perf. (%)
€276.40
23.08.22
-
23.08.23
-37.30%
23.08.23

buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€4.44
22.08.22
-
22.08.23
-29.73%
03.09.22

Could be very worthwhile Investment >20% year
buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€4.76
22.08.22
€16.00
22.08.23
-34.45%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
Beyond Meat Inc

Start price
Target price
Perf. (%)
€29.31
21.08.22
-
21.08.23
-63.32%
22.08.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€76.50
21.08.22
€230.00
21.08.23
6.54%
04.09.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€214.90
21.08.22
€87.00
21.08.23
-3.44%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group